82 related articles for article (PubMed ID: 12207118)
1. Effect of SMP-500, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on serum cholesterol level and LDL cholesterol clearance in hamsters with induced hyperlipidemia.
Ioriya K; Kino K; Sato YF; Ohashi N
Pharmacology; 2002 Oct; 66(2):107-14. PubMed ID: 12207118
[TBL] [Abstract][Full Text] [Related]
2. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
4. Effect of SMP-500, a novel ACAT inhibitor, on hepatic cholesterol disposition in rats.
Ioriya K; Nishimura T; Ohashi N
Lipids; 2002 Apr; 37(4):395-400. PubMed ID: 12030320
[TBL] [Abstract][Full Text] [Related]
5. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
Matsui Y; Horiuchi K; Yamamoto K; Kanai K
Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
[TBL] [Abstract][Full Text] [Related]
7. TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters.
Sugiyama Y; Odaka H; Itokawa S; Ishikawa E; Tomari Y; Ikeda H
Atherosclerosis; 1995 Nov; 118(1):145-53. PubMed ID: 8579624
[TBL] [Abstract][Full Text] [Related]
8. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
Vaziri ND; Liang K
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
[TBL] [Abstract][Full Text] [Related]
9. [Hypolipidemic action of F-1394, an acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, in high-fat diet fed beagle dogs].
Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
Yakugaku Zasshi; 1997 Apr; 117(4):233-41. PubMed ID: 9167444
[TBL] [Abstract][Full Text] [Related]
10. Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity.
Kusunoki J; Aragane K; Kitamine T; Kozono H; Kano K; Fujinami K; Kojima K; Chiwata T; Sekine Y
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):171-8. PubMed ID: 10634814
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility.
Ban H; Muraoka M; Ioriya K; Ohashi N
Bioorg Med Chem Lett; 2006 Jan; 16(1):44-8. PubMed ID: 16242323
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
[TBL] [Abstract][Full Text] [Related]
13. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
14. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I
Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933
[TBL] [Abstract][Full Text] [Related]
15. Effect of VULM 1457, an ACAT inhibitor, on serum lipid levels and on real time red blood cell flow in diabetic and non-diabetic hamsters fed high cholesterol-lipid diet.
Vojtassáková E; Syneková M; Tazká D; Mátyás S; Hózová R; Sadlonová I; Svec P
Gen Physiol Biophys; 2007 Dec; 26(4):254-9. PubMed ID: 18281742
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of monatepil maleate on acyl-CoA:cholesterol acyltransferase activity in the liver of cholesterol-fed Japanese monkeys.
Sumiya T; Ikeno A; Kato H; Fujitani B; Masuda Y; Hosoki K; Miyazaki M
Am J Hypertens; 1997 Jul; 10(7 Pt 1):779-85. PubMed ID: 9234833
[TBL] [Abstract][Full Text] [Related]
17. Bioavailable acyl-CoA: cholesterol acyltransferase inhibitor with anti-peroxidative activity: synthesis and biological activity of novel indolinyl amide and urea derivatives.
Kamiya S; Shirahase H; Yoshimi A; Nakamura S; Kanda M; Matsui H; Kasai M; Takahashi K; Kurahashi K
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):817-27. PubMed ID: 10866142
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT).
Ohnuma S; Muraoka M; Ioriya K; Ohashi N
Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
[TBL] [Abstract][Full Text] [Related]
20. Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters.
Li XY; Zhao ZX; Huang M; Feng R; He CY; Ma C; Luo SH; Fu J; Wen BY; Ren L; Shou JW; Guo F; Chen Y; Gao X; Wang Y; Jiang JD
J Transl Med; 2015 Aug; 13():278. PubMed ID: 26310319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
